
How FDA and DOJ Are Building Med Spa Cases in 2026: DSCSA Supply Records, Medicare Claims, and the Florida Exposure
The FDA's first-ever DSCSA warning letter to a dispenser signals a fundamental shift in federal med spa enforcement. Supply-chain tracing and Medicare claims analytics are building cases before clinics know they are targets. Aaron Cohen explains the exposure and what Florida med spas need to do now.












